| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017PLoSO..1279356K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0179356 |
| P932 | PMC publication ID | 5480889 |
| P698 | PubMed publication ID | 28640889 |
| P50 | author | Ian A Myles | Q59689517 |
| P2093 | author name string | Mark D Kieh | |
| Elim M Cho | |||
| P2860 | cites work | Transmission dynamics and control of Ebola virus disease (EVD): a review | Q21146685 |
| Anatomy of open access publishing: a study of longitudinal development and internal structure | Q21245304 | ||
| The holographic principle | Q21563880 | ||
| Review of Ebola Virus Infections in Domestic Animals | Q22306410 | ||
| Learning from Ebola Virus: How to Prevent Future Epidemics | Q22680677 | ||
| Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak | Q23000449 | ||
| Effective Communication During an Influenza Pandemic: The Value of Using a Crisis and Emergency Risk Communication Framework | Q23021109 | ||
| Exposure to blood-containing aerosols in the operating room: a preliminary study | Q23919155 | ||
| Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease | Q24187946 | ||
| Development of vaccines for prevention of Ebola virus infection | Q38294943 | ||
| Small molecule inhibitors of ebola virus infection | Q38297376 | ||
| Anesthetic Implications of Ebola Patient Management: A Review of the Literature and Policies | Q38304609 | ||
| Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases | Q38321330 | ||
| Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections | Q38323841 | ||
| A retrospective and prospective analysis of the west African Ebola virus disease epidemic: robust national health systems at the foundation and an empowered WHO at the apex | Q24574410 | ||
| Emerging targets and novel approaches to Ebola virus prophylaxis and treatment | Q24597625 | ||
| Transmission of Ebola virus from pigs to non-human primates | Q24612028 | ||
| Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences | Q24621020 | ||
| Ebola haemorrhagic fever | Q24629338 | ||
| Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis | Q26783097 | ||
| Ebola and blood transfusion: existing challenges and emerging opportunities | Q26787204 | ||
| Ebola: a holistic approach is required to achieve effective management and control | Q26823792 | ||
| General introduction into the Ebola virus biology and disease | Q26864034 | ||
| Ebola virus vaccines: an overview of current approaches | Q26999232 | ||
| Addressing Ebola-related stigma: lessons learned from HIV/AIDS | Q27000992 | ||
| Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection | Q27008824 | ||
| The Ebola crisis: perspectives from European Public Health | Q27014131 | ||
| Drug development for controlling Ebola epidemic - a race against time | Q27027886 | ||
| Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections | Q27485491 | ||
| Ebola: translational science considerations | Q28082994 | ||
| Transmission of Ebola viruses: what we know and what we do not know | Q28083565 | ||
| The determinants of spread of Ebola virus disease - an evidence from the past outbreak experiences | Q28083700 | ||
| Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives | Q28084509 | ||
| Understanding ebola virus transmission | Q28088529 | ||
| Investigating journals: The dark side of publishing | Q28287952 | ||
| Disease detection or public opinion reflection? Content analysis of tweets, other social media, and online newspapers during the measles outbreak in The Netherlands in 2013 | Q28648382 | ||
| Mass Media and the Contagion of Fear: The Case of Ebola in America | Q28648511 | ||
| 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings | Q29619731 | ||
| Ethics for pandemics beyond influenza: Ebola, drug-resistant tuberculosis, and anticipating future ethical challenges in pandemic preparedness and response | Q30202269 | ||
| Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units | Q30203304 | ||
| Risks to healthcare workers with emerging diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu. | Q30203307 | ||
| Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease. | Q30203624 | ||
| Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School. | Q30203666 | ||
| Ebola virus disease in Africa: epidemiology and nosocomial transmission. | Q30204852 | ||
| Care of the child with Ebola virus disease. | Q30204887 | ||
| Ebola in the United States | Q30205692 | ||
| Ebola in children: epidemiology, clinical features, diagnosis and outcomes | Q30205696 | ||
| Ebola: is there a hope from treatment with cardiovascular drugs? | Q44093450 | ||
| Thousands of Ebola survivors experience serious medical complications | Q44099872 | ||
| From Planck Data to Planck Era: Observational Tests of Holographic Cosmology. | Q53802676 | ||
| Communicating the science of climate change | Q56094952 | ||
| Ebola virus disease | Q56552439 | ||
| Distribution of glycoconjugates in human skin appendages | Q69273948 | ||
| Ebola virus disease and social media: A systematic review. | Q30248962 | ||
| Ebola virus convalescent blood products: where we are now and where we may need to go. | Q30369241 | ||
| Ebola Virus Disease: A Review of Its Past and Present. | Q30378110 | ||
| Against conventional wisdom: when the public, the media, and medical practice collide | Q33645368 | ||
| Assessment of the risk of Ebola virus transmission from bodily fluids and fomites | Q34007630 | ||
| Ebola virus (EBOV) infection: Therapeutic strategies | Q34042632 | ||
| Ebola and marburg hemorrhagic fever | Q34118205 | ||
| Assessing the international spreading risk associated with the 2014 west african ebola outbreak | Q34214619 | ||
| The 2014 Ebola virus disease outbreak in West Africa | Q34418736 | ||
| The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet | Q34435453 | ||
| Ebola hemorrhagic fever: genetic biomarkers and vaccine development | Q34439851 | ||
| Ebola virus disease: an update for anesthesiologists and intensivists | Q34446478 | ||
| What clinicians should know about the 2014 Ebola outbreak | Q34451717 | ||
| Ebola virus as a sexually transmitted infection | Q34453511 | ||
| Treatment of ebola virus disease | Q34460182 | ||
| Ebola haemorrhagic fever virus: pathogenesis, immune responses, potential prevention | Q34463557 | ||
| Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives | Q34463562 | ||
| Molecular mechanisms of Ebola virus pathogenesis: focus on cell death | Q34478514 | ||
| Newsprint coverage of smoking in cars carrying children: a case study of public and scientific opinion driving the policy debate | Q34504729 | ||
| Ebola virus outbreaks in Africa: past and present | Q34552637 | ||
| Emergency medical services public health implications and interim guidance for the Ebola virus in the United States | Q34607841 | ||
| Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak | Q34863198 | ||
| The multiple roles of sGP in Ebola pathogenesis | Q34869463 | ||
| Ebola virus: a clear and present danger | Q34917106 | ||
| What the newspapers say about medication adherence: a content analysis. | Q35006930 | ||
| The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases | Q35532972 | ||
| Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak | Q35598919 | ||
| Ebola virus entry: a curious and complex series of events | Q35619456 | ||
| Improving attrition rates in Ebola virus drug discovery | Q35678774 | ||
| Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics. | Q35816268 | ||
| Social Consequences of Ebola Containment Measures in Liberia. | Q35864368 | ||
| Please Like Me: Facebook and Public Health Communication | Q36134405 | ||
| Ebola virus disease. | Q36449434 | ||
| Ebola virus: melatonin as a readily available treatment option. | Q38328156 | ||
| Ebola and Marburg haemorrhagic fever. | Q38347195 | ||
| Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus | Q38349661 | ||
| The evolution of Ebola virus disease outbreaks | Q38360876 | ||
| Ebola virus disease control in Poland - are we ready for fight? | Q38360879 | ||
| Ebola virus disease - pathogenesis, clinical presentation and management | Q38360884 | ||
| Progress in the Diagnosis and Control of Ebola Disease. | Q38365987 | ||
| Ebola Virus Disease: A Perspective for the United States | Q38366724 | ||
| Laboratory-acquired lethal infections by potential bioweapons pathogens including Ebola in 2014. | Q38384078 | ||
| Ebola viral disease: What should be done to combat the epidemic in 2014? | Q38384089 | ||
| Ebola virus disease: societal challenges and new treatments | Q38388679 | ||
| Current status of chemically synthesized inhibitors of Ebola virus | Q38390748 | ||
| Selected aspects of filoviruses in the view of Ebola virus disease epidemic | Q38415547 | ||
| Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? | Q38424462 | ||
| Ebola virus: current and future perspectives. | Q38440833 | ||
| Immunology of protection from Ebola virus infection | Q38462668 | ||
| Ebola virus outbreak, updates on current therapeutic strategies | Q38473251 | ||
| Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection | Q38478474 | ||
| Global health security: the wider lessons from the west African Ebola virus disease epidemic | Q38489946 | ||
| Signaling through RIG-I and type I interferon receptor: Immune activation by Newcastle disease virus in man versus immune evasion by Ebola virus (Review). | Q38496426 | ||
| Ebola virus disease and the veterinary perspective | Q38504945 | ||
| Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. | Q38515079 | ||
| Ebola: a review for emergency providers | Q38524941 | ||
| Development of experimental and early investigational drugs for the treatment of Ebola virus infections | Q38524949 | ||
| Ebola virus disease: review and implications for dentistry in Ireland | Q38569082 | ||
| The Ebola Virus and Human Rights Concerns in Africa | Q38742373 | ||
| Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. | Q38858365 | ||
| Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach. | Q38929738 | ||
| Social Media Messages in an Emerging Health Crisis: Tweeting Bird Flu. | Q38982970 | ||
| Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. | Q40132994 | ||
| Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences | Q40163432 | ||
| Understanding bleeding in ebola virus disease | Q40169485 | ||
| Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces | Q40342577 | ||
| Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. | Q40479964 | ||
| Characteristics of blood-containing aerosols generated by common powered dental instruments | Q41676833 | ||
| Crisis and emergency risk communication as an integrative model | Q42026093 | ||
| A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact | Q37071067 | ||
| Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. | Q37896703 | ||
| Characterization of host immune responses in Ebola virus infections | Q38205274 | ||
| Ethical considerations of experimental interventions in the Ebola outbreak | Q38243093 | ||
| Caring for critically ill patients with ebola virus disease. Perspectives from West Africa. | Q38244204 | ||
| Does this patient have Ebola virus disease? | Q38245691 | ||
| Ebola and other viral haemorrhagic fevers: a local operational approach | Q38248666 | ||
| Ebola in West Africa: be aware and prepare | Q38254038 | ||
| Ebola virus disease: potential use of melatonin as a treatment | Q38254942 | ||
| The threat of Ebola: an update | Q38258223 | ||
| Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses | Q38258245 | ||
| A primer on Ebola for clinicians | Q38261065 | ||
| Clinical presentation and management of severe Ebola virus disease | Q38264960 | ||
| Ebola virus disease, transmission risk to laboratory personnel, and pretransfusion testing | Q38268877 | ||
| Potential and emerging treatment options for Ebola virus disease | Q38270149 | ||
| Ebola virus outbreak 2014: clinical review for emergency physicians | Q38279636 | ||
| Ebola virus disease: a highly fatal infectious disease reemerging in West Africa. | Q38279676 | ||
| The role of hospitalists in the Ebola response in the United States and abroad | Q38282561 | ||
| Outbreaks-of Ebola virus disease in the West African sub-region. | Q38283078 | ||
| Development of therapeutics for treatment of Ebola virus infection. | Q38286766 | ||
| Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection? | Q38289952 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Orthoebolavirus zairense | Q10538943 |
| Ebola hemorrhagic fever | Q51993 | ||
| P304 | page(s) | e0179356 | |
| P577 | publication date | 2017-06-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak | |
| P478 | volume | 12 |
Search more.